Il2rg Gene-Targeted Severe Combined Immunodeficiency Pigs

被引：126

作者：

Suzuki, Shunichi ^{[3
]}

Iwamoto, Masaki ^{[5
]}

Saito, Yoriko ^{[1
]}

Fuchimoto, Daiichiro ^{[3
]}

Sembon, Shoichiro ^{[3
]}

Suzuki, Misae ^{[3
]}

Mikawa, Satoshi ^{[4
]}

Hashimoto, Michiko ^{[5
]}

Aoki, Yuki ^{[1
]}

Najima, Yuho ^{[1
]}

Takagi, Shinsuke ^{[1
]}

Suzuki, Nahoko ^{[1
]}

Suzuki, Emi ^{[2
]}

Kubo, Masanori ^{[6
]}

Mimuro, Jun ^{[7
]}

Kashiwakura, Yuji ^{[7
]}

Madoiwa, Seiji ^{[7
]}

Sakata, Yoichi ^{[7
]}

Perry, Anthony C. F. ^{[8
]}

Ishikawa, Fumihiko ^{[1
]}

Onishi, Akira ^{[3
]}

机构：

[1] RIKEN Res Ctr Allergy & Immunol, Res Unit Human Dis Model, Yokohama, Kanagawa 2300045, Japan

[2] RIKEN Res Ctr Dev Biol, Lab Mammalian Mol Embryol, Kobe, Hyogo 6500047, Japan

[3] Natl Inst Agrobiol Sci, Transgen Anim Res Ctr, Tsukuba, Ibaraki 3050901, Japan

[4] Natl Inst Agrobiol Sci, Anim Genome Res Unit, Tsukuba, Ibaraki 3050901, Japan

[5] Prime Tech Ltd, Tsuchiura, Ibaraki 3000841, Japan

[6] Natl Inst Anim Hlth, Ctr Anim Dis Control & Prevent, Tsukuba, Ibaraki 3050856, Japan

[7] Jichi Med Univ, Ctr Mol Med, Div Cell & Mol Med, Shimotsuke, Tochigi 3290498, Japan

[8] Univ Bath, Dept Biol & Biochem, Lab Mammalian Mol Embryol, Bath BA2 7AY, Avon, England

来源：

CELL STEM CELL | 2012年 / 10卷 / 06期

关键词：

INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; T-CELL PROLIFERATION; IL-2; RECEPTOR; BETA-CHAIN; FUNCTIONAL COMPONENT; CYTOPLASMIC DOMAINS; IMMUNE-SYSTEM; CLONED MICE; STEM-CELLS; EXPRESSION;

D O I：

10.1016/j.stem.2012.04.021

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

A porcine model of severe combined immunodeficiency (SCID) promises to facilitate human cancer studies, the humanization of tissue for xenotransplantation, and the evaluation of stem cells for clinical therapy, but SCID pigs have not been described. We report here the generation and preliminary evaluation of a porcine SCID model. Fibroblasts containing a targeted disruption of the X-linked interleukin-2 receptor gamma chain gene, Il2rg, were used as donors to generate cloned pigs by serial nuclear transfer. Germline transmission of the Il2rg deletion produced healthy Il2rg(+/-) females, while Il2rg(-/Y) males were athymic and exhibited markedly impaired immunoglobulin and T and NK cell production, robustly recapitulating human SCID. Following allogeneic bone marrow transplantation, donor cells stably integrated in Il2rg(-/Y) heterozygotes and reconstituted the Il2rg(-/Y) lymphoid lineage. The SCID pigs described here represent a step toward the comprehensive evaluation of preclinical cellular regenerative strategies.

引用

页码：753 / 758

页数：6

共 50 条

[41] Gene Correction of IL2RG in Human Hematopoietic Stem and Progenitor Cells
Conway, Anthony
Guschin, Dmitry Y.
Genovese, Pietro
Lombardo, Angelo
Naldini, Luigi
Gregory, Philip D.
Holmes, Michael C.
Cost, Gregory J.
MOLECULAR THERAPY, 2015, 23 : S273 - S273
[42] A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells
Kuijpers, Taco W.
van Leeuwen, Ester M. M.
Barendregt, Barbara H.
Klarenbeek, Paul
aan de Kerk, Daan J.
Baars, Paul A.
Jansen, Machiel H.
de Vries, Niek
van Lier, Rene A. W.
van der Burg, Mirjam
HAEMATOLOGICA, 2013, 98 (07) : 1030 - 1038
[43] Gene therapy -: Is IL2RG oncogenic in T-cell development?
Pike-Overzet, Karin
de Ridder, Dick
Weerkamp, Floor
Baert, Miranda R. M.
Verstegen, Monique M.
Brugman, Martijn H.
Howe, Steven J.
Reinders, Marcel J. T.
Thrasher, Adrian J.
Wagemaker, Gerard
van Dongen, Jacques J. M.
Staal, Frank J. T.
NATURE, 2006, 443 (7109) : E5 - E5
[44] THE GAMMA-CHAIN OF IL-2 RECEPTOR (IL2RG) MAPS TO XQ13.1 AND IS MUTATED IN HUMAN X-LINKED SEVERE COMBINED IMMUNODEFICIENCY, SCIDX1
PUCK, JM
DESCHENES, SM
BROWN, CJ
WILLARD, HF
HENTHORN, PS
AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 10 - 10
[45] Targeted gene correction for the treatment of severe combined immunodeficiency caused by mutations in the IL7R gene
Romito, M.
Rai, R.
Santilli, G.
Thrasher, A. J.
Cavazza, A.
HUMAN GENE THERAPY, 2018, 29 (12) : A111 - A111
[46] Targeted gene correction for the treatment of Severe Combined Immunodeficiency caused by mutations in the IL7R gene
Romito, M.
Rai, R.
Santilli, G.
Thrasher, A.
Cavazza, A.
HUMAN GENE THERAPY, 2019, 30 (11) : A80 - A81
[47] Perspectives in newborn screening for SCID in Japan. Case report: newborn screening identified X-linked severe combined immunodeficiency with a novel IL2RG variant
Beppu, Shiro
Nishikawa, Takuro
Tomomasa, Dan
Hijikata, Atsushi
Kasabata, Hiroshi
Terazono, Hideyuki
Ikawa, Kazuro
Nakamura, Tatsuro
Horikawa, Shogo
Nagahama, Jun
Nakamura, Aki
Abematsu, Takanari
Nakagawa, Shunsuke
Oketani, Kaoru
Kanegane, Hirokazu
Okamoto, Yasuhiro
FRONTIERS IN IMMUNOLOGY, 2024, 15
[48] CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency
Xinru Wei
Yunxin Lai
Baiheng Li
Le Qin
Youdi Xu
Simiao Lin
Suna Wang
Qiting Wu
Qiubin Liang
Guohua Huang
Qiuhua Deng
Pentao Liu
Donghai Wu
Liangxue Lai
Yao Yao
Peng Li
Scientific Reports, 7
[49] Gene replacement of IL2RG for SCID defect associated with increased risk of lymphoma in mice
不详
CANCER BIOLOGY & THERAPY, 2006, 5 (05) : 462 - 463
[50] Is IL2RG oncogenic in T-cell development?
Karin Pike-Overzet
Dick de Ridder
Floor Weerkamp
Miranda R. M. Baert
Monique M. Verstegen
Martijn H. Brugman
Steven J. Howe
Marcel J. T. Reinders
Adrian J. Thrasher
Gerard Wagemaker
Jacques J. M. van Dongen
Frank J. T. Staal
Nature, 2006, 443 : E5 - E5

← 1 2 3 4 5 →